These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25546767)

  • 1. Subclinical infection and dosing in primary immunodeficiencies.
    Jolles S
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):67-9. PubMed ID: 25546767
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not Available].
    Valkova K; Vallelian F
    Praxis (Bern 1994); 2017; 106(6):287-294. PubMed ID: 28299997
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recurrent respiratory tract infections].
    Heidgen FJ; Ko YD; Fronhoffs S; Vetter H
    Praxis (Bern 1994); 1995 Sep; 84(39):1079-82. PubMed ID: 7481311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7th International Immunoglobulin Conference: Immunodeficiencies.
    Schmidt RE; Ochs HD
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):3-4. PubMed ID: 25546741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considering the demand for and prioritization of intravenous immunoglobulin.
    Orange JS
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):78-82. PubMed ID: 25546771
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immunoglobulin and immune response.
    Kaveri SV; Lecerf M; Saha C; Kazatchkine MD; Lacroix-Desmazes S; Bayry J
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):94-6. PubMed ID: 25546777
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on Infections in Primary Antibody Deficiencies.
    Demirdag YY; Gupta S
    Front Immunol; 2021; 12():634181. PubMed ID: 33643318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?
    Seppänen M; Aghamohammadi A; Rezaei N
    Expert Rev Clin Immunol; 2014 Jan; 10(1):1-5. PubMed ID: 24325452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective dosing strategies for therapeutic immunoglobulin: managing wear-off effects in antibody replacement to immunomodulation.
    Misbah SA
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):70-1. PubMed ID: 25546768
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigating recurrent respiratory infections in primary care.
    Wood P; Peckham D
    BMJ; 2009 Nov; 339():b4118. PubMed ID: 19910402
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcutaneous immunoglobulin infusion as an alternative to intravenous immunoglobulin.
    Radinsky S; Bonagura VR
    J Allergy Clin Immunol; 2003 Sep; 112(3):630-3. PubMed ID: 13679829
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous immunoglobulin therapy in an 11-year-old patient with common variable immunodeficiency and von Willebrand disease.
    Arora R; Newton TC; Nelson MR
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):367-70. PubMed ID: 17941286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of enteral immunoglobulin in NEMO syndrome for eradication of persistent symptomatic norovirus enteritis.
    Wu S; Orange JS; Chiou EH; Nicholas SK; Seeborg F; Gwalani LA; Kearney D; Rider NL; Rasalingam S; Hanson IC
    J Allergy Clin Immunol Pract; 2016; 4(3):539-541.e1. PubMed ID: 26795245
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and immunologic features of pediatric patients with common variable immunodeficiency and respiratory complications.
    Aydogan M; Eifan AO; Gocmen I; Ozdemir C; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2008; 18(4):260-5. PubMed ID: 18714533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of lichenoid drug eruption associated with subcutaneous immunoglobulin therapy.
    Beccastrini E; Emmi G; Caproni M; Antiga E; Francalanci S; Lorenzoni A; Emmi L
    Clin Immunol; 2011 May; 139(2):228-30. PubMed ID: 21402497
    [No Abstract]   [Full Text] [Related]  

  • 16. Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin home therapy in a patient with primary immunodeficiency.
    Knight E; Carne E; Novak B; El-Shanawany T; Williams P; Pickersgill T; Jolles S
    J Clin Pathol; 2010 Sep; 63(9):846-7. PubMed ID: 20671049
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic efficacy of human immunoglobulins related to their antibody activity against circulating antigens in children with recurrent infections].
    Masson PL
    Presse Med; 1983 Nov; 12(41):2592-4. PubMed ID: 6228794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of selective IgA deficiency to common variable immunodeficiency in a 16 year old boy.
    Litzman J; Burianova M; Thon V; Lokaj J
    Allergol Immunopathol (Madr); 1996; 24(4):174-6. PubMed ID: 8939274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological investigation of hypogammaglobulinemia].
    Jureen R; Ulvestad E
    Tidsskr Nor Laegeforen; 1999 Mar; 119(7):940-3. PubMed ID: 10210954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive immunodeficiency in a patient with IgA deficiency.
    Gutierrez MG; Kirkpatrick CH
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):297-301. PubMed ID: 9357373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.